Fetal-maternal microchimerism in normal parous females and parous female cancer patients
Authors:
- Bushra HaqBHBushra Haq
- Richard K. ShadduckRSRichard K. Shadduck
- Sri Lakshmi JasthySJSri Lakshmi Jasthy
- John ListerJLJohn Lister
- 1 September 2008
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 36 (9) , 1073-1077
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Direct quantification of fetal cells in maternal blood by real‐time PCRPrenatal Diagnosis, 2006
- Impact of fetal-maternal tolerance in hematopoietic stem cell transplantationArchivum Immunologiae et Therapiae Experimentalis, 2006
- Fetal–maternal microchimerism: impact on hematopoietic stem cell transplantationCurrent Opinion in Immunology, 2005
- Possible roles and determinants of microchimerism in autoimmune and other disordersAutoimmunity Reviews, 2004
- Quantification of maternal microchimerism by HLA‐specific real‐time polymerase chain reaction: Studies of healthy women and women with sclerodermaArthritis & Rheumatism, 2004
- Male DNA in female donor apheresis and CD34-enriched productsBlood, 2003
- Non–T-cell–depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerismBlood, 2003
- Microchimerism in Human Health and DiseaseAutoimmunity, 2003
- Microchimerism and the pathogenesis of systemic sclerosisCurrent Opinion in Rheumatology, 1998
- Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum.Proceedings of the National Academy of Sciences, 1996